Bayforest Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.7K Buy
+204
New +$67K 0.07% 515
2025
Q4
Sell
-1,527
Closed -$493K 839
2025
Q3
$493K Buy
1,527
+146
+11% +$45.4K 0.23% 147
2025
Q2
$537K Buy
1,381
+1,025
+288% +$412K 0.23% 158
2025
Q1
$155K Buy
+356
New +$143K 0.07% 434

Other funds holding ELV

Bayforest Capital's ELV Position: Q1 2026 in Review

Bayforest Capital opened a new position in Elevance Health (ELV) in Q1 2026: 204 shares worth $59.7K. The stake represents 0.07% of the portfolio and ranks #515 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in ELV as recently as Q3 2025.

Bayforest Capital first reported a position in ELV in Q1 2025 and has held it in 4 quarters since. The position peaked at $537K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Bayforest Capital held 204 shares of Elevance Health worth $59.7K as of Q1 2026.
  • Elevance Health was a new Bayforest Capital position in Q1 2026.
  • Elevance Health made up 0.07% of Bayforest Capital's portfolio in Q1 2026, its #515 holding.
  • Bayforest Capital first reported a position in Elevance Health in Q1 2025 and has held it in 4 quarters since.
  • Bayforest Capital's Elevance Health position peaked at $537K in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.